Nerve growth factor and its receptors on onset and diagnosis of ovarian cancer
Authors:
Open Access
- 6 July 2017
- journal article
- retracted article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (3) , 2864-2868
Abstract
The effect of nerve growth factor (NGF) and its receptors on the onset and diagnosis of ovarian cancer was investigated. A total of 35 patients with ovarian tumor admitted in the First Affiliated Hospital of Nanchang University from July 2014 to July 2015 were selected as study subjects and were divided into an observation group (including 21 patients with benign ovarian tumor, and 14 patients with malignant ovarian tumor), and a control group (21 healthy women). The quantity of expression of mRNA in NGF and its receptors (TrkA and p75NTR) was detected using fluorescent quantitative PCR. The protein expression of NGF, TrkA and p75NTR in different study samples was detected using ELISA and western blot analysis. The location of expression was determined using immunohistochemistry. The positive cell rate in different samples was analyzed. Compared with healthy women, the quantity of expression of mRNA in NGF, TrkA and p75NTR in patients with ovarian cancer was increased significantly. The results of ELISA showed that the quantity of protein expression of NGF, TrkA and p75NTR was 0.98±0.12, 1.23±0.14 and 0.76±0.07 µg/l in healthy women, and was 3.21±0.16, 5.28±0.25 and 2.97±0.13 µg/l, respectively, in women with ovarian tumor, and there were statistically significant differences (P<0.05), and the level of expression in patients with malignant ovarian tumor was significantly higher than that in patients with benign ovarian cancer. Western blot analysis also showed that the quantity of expression of NGF, TrkA and p75NTR gene in women with ovarian cancer was significantly higher than that in healthy women. Immunohistochemical results showed that the number of positive cells of NGF, TrkA and p75NTR gene in the tissue of patients with ovarian cancer (89.5, 93.4 and 82.5%, respectively) was significantly higher than those in healthy ovarian tissue (9.4, 10.3 and 7.9%, respectively). In conclusion, NGF and its receptor can contribute to the occurrence of ovarian cancer, and the onset condition of ovarian cancer can be diagnosed through the detection of high or low expression of NGF and its receptors.Keywords
This publication has 19 references indexed in Scilit:
- The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesiaNaunyn-Schmiedeberg's Archives of Pharmacology, 2012
- The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9Supportive Care in Cancer, 2012
- Clinical Significance and Expression of PAF and TNF-alpha in Seminal Plasma of Leukocytospermic PatientsMediators of Inflammation, 2012
- Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasionCytokine, 2012
- Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapyChinese Journal of Cancer Research, 2012
- Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal disseminationGastric Cancer, 2011
- Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stressScience China Life Sciences, 2011
- Collective Chemotaxis Requires Contact-Dependent Cell PolarityDevelopmental Cell, 2010
- Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?European Journal of Nuclear Medicine and Molecular Imaging, 2010
- Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of actionWorld Journal of Biological Chemistry, 2010